iTonic Holdings Ltd(ITOC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 21 at 4:00 PM ET (Korea 10/22 05:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -4.22 | Insider Own | 17.46% | Shs Outstand | 6.8M | Perf Week | -6.84% |
| Market Cap | 0.03B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 6.0M | Perf Month | -30.97% |
| Enterprise Value | 0.03B | PEG | - | EPS next Q | - | Inst Own | 0.24% | Short Float | 0.21% | Perf Quarter | -20.98% |
| Income | -0.01B | P/S | 46.25 | EPS this Y | - | Inst Trans | - | Short Ratio | 0.24 | Perf Half Y | -27.36% |
| Sales | 0.00B | P/B | 1.1 | EPS next 5Y | - | ROA | -56.27% | Short Interest | 0.01M | Perf YTD | -47.42% |
| Book/sh | 3.22 | P/C | 11.67 | EPS past 3/5Y | - | ROE | -62.99% | 52W High | -80.76% ($18.40) | Perf Year | -64.9% |
| Cash/sh | 0.3 | P/FCF | - | Sales past 3/5Y | -8.37% -7.12% | ROIC | -37.75% | 52W Low | 8.16% ($3.27) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -62.68% | Gross Margin | 33.25% | Volatility(W/M) | 9.81% 11.43% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 44.64 | Sales Y/Y TTM | 82.31% | Oper. Margin | -1471.55% | ATR (14) | 0.49 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 17.36 | EPS Q/Q | 39.89% | Profit Margin | -1602.33% | RSI (14) | 38.3 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 17.39 | Sales Q/Q | 49.47% | SMA20 | -13.17% ($4.08) | Beta | 2.83 | Target Price | - |
| Payout | - | Debt/Eq | 0.01 | Earnings | - | SMA50 | -21.81% ($4.53) | Rel Volume | 0.04 | Prev Close | $3.35 |
| Employees | - | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -33.93% ($5.36) | Avg Volume(3M) | 0.05M | Price | $3.54 |
| IPO | 2024/9/5 | Option/Short | No/Yes | Trades | 186 | Volume | 2,301 | Change | 5.67% |
This micro-cap medical device company focuses on home healthcare AI platforms and radiation therapy (brachytherapy) planning software. Formerly known as Pheton Holdings, it trades on Nasdaq under its new name and ticker following a corporate renaming in January 2026.
Over the past 1 year, on the lower side
81% below its 1-year high.
Traded less than usual. That is 4% of its average volume.
ITOC has a sound balance sheet but weak earning power
Losses exceed revenue. The business is barely earning yet.
Tap to view numbers
Relative to sales, it looks expensive
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $4,625. Peers typically go for $148.
Tap to view numbers
Holding long would have lost money
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 0.2%.
Tap to view numbers
It ranks #107 of 142 in the industry
Based on market cap of $26M.
NNOX#105 Nano X Imaging Ltd $30M PER - 
NSYS#106 Nortech Systems Inc $29M PER 29.5 ITOC#107 iTonic Holdings Ltd $26M PER - 
PMI#108 Picard Medical Inc $23M PER - 
NSPR#109 InspireMD Inc $21M PER - 
FAQ
What kind of company is ITOC?
ITOC belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of ITOC?
The market cap of ITOC is approximately $26M, ranking 5,145 within its sector.
What is the 52-week high and low for ITOC?
ITOC has recorded a 52-week high of $18.40 and a low of $3.27.
